This CRISPR-mediated interference/activation technology is especially relevant for stroke research since many stroke-associated risk variants are in a non-coding site which could affect the expression of neighboring genes (i.e., rs2107595 SNP in the HDAC9 gene) as well as being involved in the long-range regulation of gene expression in a tissue-specific way. This evidence concerns the gene HDAC9 and stroke disorder.